← All stocks

NEOGEN CORP

NEOG No buying or selling
CIK 0000711377 #1852 in the set updated 18 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

20 insiders · 0 transactions

There is no salary here to measure against. NEOGEN CORP's chief executive is paid a token, so dividing a holding by it says nothing.

Which is why this company is in neither direction of the chief executive filter on the transactions page. A stake that cannot be expressed as a multiple is not the same thing as a small one.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
ADENT JOHN EDWARD
Former CEO
363,081
$4.29M
+103.3%
Nassif Mikheal
CEO
142,705
$1.69M
Jones Douglas Edward
Former COO
100,881
$1.19M
+100.0%
BOREL JAMES C
Director
94,570
$1.12M
Naemura David H.
Former CFO
90,388
$1.07M
Rocklin Amy M
Former Chief Legal Officer
82,182
$970.57K
Riggsbee Richard Bryan
CFO
51,502
$608.24K
BOEHM WILLIAM T
Director
47,913
$565.85K
+76.6%
Tobin James P
Director
43,347
$511.93K
+124.1%
Stacey Jennifer Evans
Chief Legal Officer
38,627
$456.18K
CAPELLO JEFFREY D
Director
30,725
$362.86K
Gupta Aashima
Director
27,790
$328.20K
Ranalli Tamara A.
Senior Vice President
25,751
$304.12K
RODRIGUEZ RAFAEL A
Director
20,821
$245.90K
Wainer Andrea F
Director
19,769
$233.47K
Bernard Thierry
Director
19,769
$233.47K
Pelossof Avi
Director
19,386
$228.95K
Woteki Catherine E
Director
19,117
$225.77K
Green Ronald D
Director
18,654
$220.30K
Moylan John Patrick
Chief Accounting Officer
17,337
$204.75K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 2
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 22,762
History held since 30 Sep 2016